About: Potential role of statins in COVID-19

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: Potential role of statins in COVID-19 Goto Sponge NotDistinct Permalink

An Entity of Type : schema:ScholarlyArticle, within Data Space : wasabi.inria.fr associated with source document(s)

Attributes	Values
type	Academic Article research paper schema:ScholarlyArticle
isDefinedBy	Covid-on-the-Web dataset
title	Potential role of statins in COVID-19
Creator	Lee, Ken Dw, Sewa Gc, Phua Phua, G Sewa, D
source	Elsevier; Medline; PMC
abstract	Abstract Patients with COVID-19 infection have an increased risk of cardiovascular complications and thrombotic events. Statins are known for their pleiotropic anti-inflammatory, antithrombotic and immunomodulatory effects. They may have a potential role as adjunctive therapy to mitigate the effects of endothelial dysfunction and dysregulated inflammation in patients with COVID-19 infection.
has issue date	2020-06-02(xsd:dateTime)
bibo:doi	10.1016/j.ijid.2020.05.115
bibo:pmid	32502659
has license	els-covid
sha1sum (hex)	8f309506fde1764d0746f7466e91ed98e1fc0034
schema:url	https://doi.org/10.1016/j.ijid.2020.05.115
resource representing a document's title	Potential role of statins in COVID-19
has PubMed Central identifier	PMC7265877
has PubMed identifier	32502659
schema:publication	Int J Infect Dis
resource representing a document's body	covid:8f309506fde1764d0746f7466e91ed98e1fc0034#body_text
is schema:about of	named entity 'patients' named entity 'Statins' named entity 'Word count' named entity 'MANUSCRIPT' named entity 'PATIENTS' named entity 'manuscript' named entity 'improve' named entity 'Statins' named entity 'infection' named entity 'antithrombotic' named entity 'ACE2' named entity 'Statins' named entity 'vasoconstriction' named entity 'SARS-CoV-2' named entity 'intensive care unit' named entity 'JUPITER trial' named entity 'COVID' named entity 'statin' named entity 'ARBs' named entity 'observational studies' named entity 'confounding' named entity 'anticoagulation' named entity 'endothelial' named entity 'critically ill' named entity 'infection' named entity 'angiotensin' named entity 'statins' named entity 'receptor' named entity 'lung injury' named entity 'COVID-19 infection' named entity 'infection' named entity 'COVID' named entity 'West Africa' named entity 'Ebola' named entity 'endothelial' named entity 'venous thromboembolism' named entity 'experimental animal' named entity 'statins' named entity 'infection' named entity 'coagulopathy' named entity 'infection' named entity 'statins' named entity 'Phase 3 trials' named entity 'statin' named entity 'Infection' named entity 'thromboprophylaxis' named entity 'lung compliance' named entity 'prophylactic' named entity 'thrombolytic' named entity 'pathogenesis' named entity 'harmful effects' named entity 'ARBs' named entity 'acute respiratory distress syndrome' named entity 'SARS-CoV' named entity 'statin' named entity 'ACE2' named entity 'pulmonary embolism' named entity 'endothelial dysfunction' named entity 'viral infections' named entity 'COVID' named entity 'statin' named entity 'all-cause mortality' named entity 'COVID' named entity 'ARDS' named entity 'host response' named entity 'COVID-19' named entity 'ACE2' named entity 'ACE2' named entity 'kidney' named entity 'mechanical ventilation' named entity 'cumulative incidence' named entity 'respiratory failure' named entity 'pharmacological' named entity 'COVID' named entity 'thrombogenicity' named entity 'receptor' named entity 'influenza'

Faceted Search & Find service v1.13.91 as of Mar 24 2020

Alternative Linked Data Documents: Sponger | ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3229 as of Jul 10 2020, on Linux (x86_64-pc-linux-gnu), Single-Server Edition (94 GB total memory)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2025 OpenLink Software